{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:53Z","timestamp":1761513773694,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clbc.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T13:29:48Z","timestamp":1540819788000},"page":"e261-e269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of 21-Gene Expression Assay on Staging Estrogen Receptor\u2013Positive HER2-Negative Breast Cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Andrea","family":"Breaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3103-0179","authenticated-orcid":false,"given":"Bradley","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shesh N.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth C.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounika","family":"Mandadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"AJCC Cancer Staging Manual","key":"10.1016\/j.clbc.2018.10.005_bib1"},{"key":"10.1016\/j.clbc.2018.10.005_bib2","first-page":"113","article-title":"Changes and clarifications in the eighth edition of the AJCC cancer staging system for breast cancer","volume":"23","author":"Sanders","year":"2018","journal-title":"AJSP Rev Rep"},{"key":"10.1016\/j.clbc.2018.10.005_bib3","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1245\/s10434-017-6009-x","article-title":"Bioscore: a staging system for breast cancer patients that reflects the prognostic significance of underlying tumor biology","volume":"24","author":"Mittendorf","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2018.10.005_bib4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1634\/theoncologist.2017-0116","article-title":"Incorporating tumor characteristics to the American Joint Committee on Cancer breast cancer staging system","volume":"22","author":"Chavez-MacGregor","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2018.10.005_bib5","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A\u00a0multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2018.10.005_bib6","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1200\/JCO.2015.65.8609","article-title":"Role of patient and disease factors in adjuvant systemic therapy decision making for early-stage, operable breast cancer: American Society of Clinical Oncology endorsement of Cancer Care Ontario guideline recommendations","volume":"34","author":"Henry","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.10.005_bib7","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","article-title":"Prospective validation of a 21-gene expression assay in breast cancer","volume":"373","author":"Sparano","year":"2015","journal-title":"N\u00a0Engl J Med"},{"author":"National Comprehensive Cancer Network","key":"10.1016\/j.clbc.2018.10.005_bib8"},{"key":"10.1016\/j.clbc.2018.10.005_bib9","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1200\/JCO.2010.31.2835","article-title":"Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer","volume":"29","author":"Cuzick","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.10.005_bib10","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.5858\/134.7.e48","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clbc.2018.10.005_bib11","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.10.005_bib12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.10.005_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/07357907.2013.849725","article-title":"Routine histopathologic characteristics can predict Oncotype DX\u2122 recurrence score in subsets of breast cancer patients","volume":"31","author":"Mattes","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clbc.2018.10.005_bib14","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"year":"2002","series-title":"Categorical Data Analysis","author":"Agresti","key":"10.1016\/j.clbc.2018.10.005_bib15"},{"year":"2003","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","key":"10.1016\/j.clbc.2018.10.005_bib16"},{"key":"10.1016\/j.clbc.2018.10.005_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-017-4170-3","article-title":"Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data","volume":"163","author":"Orucevic","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.10.005_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clbc.2015.04.006","article-title":"A\u00a0validated model for identifying patients unlikely to benefit from the 21-gene recurrence score assay","volume":"15","author":"Gage","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2018.10.005_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2018.10.005_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918305615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918305615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:28Z","timestamp":1761513508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820918305615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1526820918305615"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2018.10.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of 21-Gene Expression Assay on Staging Estrogen Receptor\u2013Positive HER2-Negative Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}